Phibro Animal Health (PAHC) Construction in Progress (2013 - 2021)
Phibro Animal Health's (PAHC) quarterly Construction in Progress came in at $23.7 million in Q2 2021, down 7.52% year-on-year from $25.6 million in Q2 2020, and down 7.52% quarter-over-quarter from $25.6 million in Q2 2020.
Phibro Animal Health (PAHC) Construction in Progress (2013 - 2021) Analysis & Trends
Phibro Animal Health's Construction in Progress history runs 9 years deep, the most recent figure standing at $23.7 million for Q2 2021.
- On a quarterly basis, Construction in Progress fell 7.52% year-over-year to $23.7 million in Q2 2021; TTM through Jun 2021 was $23.7 million, a 7.52% decrease from a year earlier, with the FY2021 full-year figure at $23.7 million, down 7.52% from the prior year.
- Construction in Progress retreated to $23.7 million in Q2 2021 per PAHC's latest filing, from $25.6 million in the prior quarter.
- Across five years, Construction in Progress topped out at $25.6 million in Q2 2020 and bottomed at $2.7 million in Q2 2017.
- The 5-year median for Construction in Progress is $15.6 million (2019), against an average of $15.1 million.
- Across the five-year window, Construction in Progress plunged 51.92% in 2017 and soared 189.33% in 2018, its largest moves.
- Year by year, Construction in Progress stood at $2.7 million in 2017, then surged by 189.33% to $7.8 million in 2018, then surged by 100.82% to $15.6 million in 2019, then jumped by 63.67% to $25.6 million in 2020, then declined by 7.52% to $23.7 million in 2021.
- Per Business Quant, the three latest PAHC Construction in Progress figures stand at $23.7 million (Q2 2021), $25.6 million (Q2 2020), and $15.6 million (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 23.66 Mn |
| Jun 30, 2020 | 25.58 Mn |
| Jun 30, 2019 | 15.63 Mn |
| Jun 30, 2018 | 7.78 Mn |
| Jun 30, 2017 | 2.69 Mn |
| Jun 30, 2016 | 5.60 Mn |
| Jun 30, 2015 | 5.75 Mn |
| Jun 30, 2014 | 4.78 Mn |
| Jun 30, 2013 | 5.54 Mn |